Literature DB >> 19143408

Chimeras and human dignity.

Inmaculada de Melo-Martín1.   

Abstract

Discussions about whether new biomedical technologies threaten or violate human dignity are now common. Indeed, appeals to human dignity have played a central role in national and international debates about whether to allow particular kinds of biomedical investigations. The focus of this paper is on chimera research. I argue here that both those who claim that particular types of human-nonhuman chimera research threaten human dignity and those who argue that such threat does not exist fail to make their case. I first introduce some of the arguments that have been offered supporting the claim that the creation of certain sorts of chimeras threatens or violates human dignity. I next present opponents' assessments of such arguments. Finally I critically analyze both the critics' and the supporters' claims about whether chimera research threatens human dignity.

Entities:  

Mesh:

Year:  2008        PMID: 19143408     DOI: 10.1353/ken.0.0268

Source DB:  PubMed          Journal:  Kennedy Inst Ethics J        ISSN: 1054-6863


  5 in total

1.  Faith-based perspectives on the use of chimeric organisms for medical research.

Authors:  Chris Degeling; Rob Irvine; Ian Kerridge
Journal:  Transgenic Res       Date:  2013-11-30       Impact factor: 2.788

2.  Human-animal chimera: a neuro driven discussion? Comparison of three leading European research countries.

Authors:  Laura Yenisa Cabrera Trujillo; Sabrina Engel-Glatter
Journal:  Sci Eng Ethics       Date:  2014-06-03       Impact factor: 3.525

3.  Human dignity and the creation of human-nonhuman chimeras.

Authors:  César Palacios-González
Journal:  Med Health Care Philos       Date:  2015-11

4.  Anticipatory Governance: Bioethical Expertise for Human/Animal Chimeras.

Authors:  Alison Harvey; Brian Salter
Journal:  Sci Cult (Lond)       Date:  2012-02-21

5.  Ethical arguments concerning human-animal chimera research: a systematic review.

Authors:  Koko Kwisda; Lucie White; Dietmar Hübner
Journal:  BMC Med Ethics       Date:  2020-03-23       Impact factor: 2.652

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.